Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Interest Coverage Ratio: 2019-2025

Historic Interest Coverage Ratio for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to -12.37.

  • BridgeBio Pharma's Interest Coverage Ratio fell 48.76% to -12.37 in Q3 2025 from the same period last year, while for Sep 2025 it was -5.03, marking a year-over-year increase of 17.14%. This contributed to the annual value of -5.97 for FY2024, which is 20.07% up from last year.
  • As of Q3 2025, BridgeBio Pharma's Interest Coverage Ratio stood at -12.37, which was down 246.69% from -3.57 recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Interest Coverage Ratio ranged from a high of 0.01 in Q1 2024 and a low of -17.20 during Q1 2021.
  • For the 3-year period, BridgeBio Pharma's Interest Coverage Ratio averaged around -6.53, with its median value being -7.58 (2024).
  • In the last 5 years, BridgeBio Pharma's Interest Coverage Ratio soared by 100.23% in 2024 and then plummeted by 17,047.93% in 2025.
  • BridgeBio Pharma's Interest Coverage Ratio (Quarterly) stood at -10.94 in 2021, then soared by 40.92% to -6.46 in 2022, then slumped by 35.40% to -8.75 in 2023, then climbed by 13.41% to -7.58 in 2024, then plummeted by 48.76% to -12.37 in 2025.
  • Its Interest Coverage Ratio stands at -12.37 for Q3 2025, versus -3.57 for Q2 2025 and -2.48 for Q1 2025.